These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 1717586)

  • 1. Lipopolysaccharide-induced stimulation of CD11b/CD18 expression on neutrophils. Evidence of specific receptor-based response and inhibition by lipid A-based antagonists.
    Lynn WA; Raetz CR; Qureshi N; Golenbock DT
    J Immunol; 1991 Nov; 147(9):3072-9. PubMed ID: 1717586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different signaling pathways for CD18-mediated adhesion and Fc-mediated phagocytosis. Response of neutrophils to LPS.
    Detmers PA; Zhou D; Powell DE
    J Immunol; 1994 Sep; 153(5):2137-45. PubMed ID: 7519640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation-dependent proteolytic degradation of polymorphonuclear CD11b.
    Davey PC; Zuzel M; Kamiguti AS; Hunt JA; Aziz KA
    Br J Haematol; 2000 Dec; 111(3):934-42. PubMed ID: 11122158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane molecules which trigger the production of interleukin-1 and tumor necrosis factor-alpha by lipopolysaccharide-stimulated human monocytes.
    Couturier C; Jahns G; Kazatchkine MD; Haeffner-Cavaillon N
    Eur J Immunol; 1992 Jun; 22(6):1461-6. PubMed ID: 1376258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxemia regulates effect of lipopolysaccharide on polymorphonuclear leukocyte CD11b/CD18 expression.
    Simms HH; D'Amico R
    J Appl Physiol (1985); 1994 Apr; 76(4):1657-63. PubMed ID: 7913925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cell surface glycoprotein Mac-1 (CD11b/CD18) mediates neutrophil adhesion and modulates degranulation independently of its quantitative cell surface expression.
    Schleiffenbaum B; Moser R; Patarroyo M; Fehr J
    J Immunol; 1989 May; 142(10):3537-45. PubMed ID: 2565926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin regulation of leukocyte inflammatory functions. CD11b/CD18 enhancement of the tumor necrosis factor-alpha responses of monocytes.
    Fan ST; Edgington TS
    J Immunol; 1993 Apr; 150(7):2972-80. PubMed ID: 8095957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-macrophage colony-stimulating factor increases synthesis and expression of CR1 and CR3 by human peripheral blood neutrophils.
    Neuman E; Huleatt JW; Jack RM
    J Immunol; 1990 Nov; 145(10):3325-32. PubMed ID: 1977799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the CD11b/CD18 integrin, but not of the endothelial cell adhesion molecules ELAM-1 and ICAM-1 in tumor necrosis factor-alpha-induced neutrophil toxicity.
    von Asmuth EJ; van der Linden CJ; Leeuwenberg JF; Buurman WA
    J Immunol; 1991 Dec; 147(11):3869-75. PubMed ID: 1719092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effects of oxidized low density lipoprotein on CD11b/CD18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation.
    Lehr HA; Krombach F; Münzing S; Bodlaj R; Glaubitt SI; Seiffge D; Hübner C; von Andrian UH; Messmer K
    Am J Pathol; 1995 Jan; 146(1):218-27. PubMed ID: 7531948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive and induced phosphorylation of the alpha- and beta-chains of the CD11/CD18 leukocyte integrin family. Relationship to adhesion-dependent functions.
    Buyon JP; Slade SG; Reibman J; Abramson SB; Philips MR; Weissmann G; Winchester R
    J Immunol; 1990 Jan; 144(1):191-7. PubMed ID: 1967263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired CD14-dependent and independent response of polymorphonuclear leukocytes in preterm infants.
    Henneke P; Osmers I; Bauer K; Lamping N; Versmold HT; Schumann RR
    J Perinat Med; 2003; 31(2):176-83. PubMed ID: 12747235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of lipopolysaccharide-induced neutrophil retention. Relative contributions of adhesive and cellular mechanical properties.
    Erzurum SC; Downey GP; Doherty DE; Schwab B; Elson EL; Worthen GS
    J Immunol; 1992 Jul; 149(1):154-62. PubMed ID: 1376747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b/CD18.
    Troelstra A; de Graaf-Miltenburg LA; van Bommel T; Verhoef J; Van Kessel KP; Van Strijp JA
    J Immunol; 1999 Apr; 162(7):4220-5. PubMed ID: 10201950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of lipopolysaccharide binding to human granulocytes.
    Weersink AJ; Van Kessel KP; Van der Tol ME; Verhoef J
    Immunology; 1994 Dec; 83(4):617-23. PubMed ID: 7533136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester.
    Grey ST; Tsuchida A; Hau H; Orthner CL; Salem HH; Hancock WW
    J Immunol; 1994 Oct; 153(8):3664-72. PubMed ID: 7523500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide-induced protein tyrosine phosphorylation in human macrophages is mediated by CD14.
    Weinstein SL; June CH; DeFranco AL
    J Immunol; 1993 Oct; 151(7):3829-38. PubMed ID: 7690817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two pathways of CD11b/CD18-mediated neutrophil aggregation with different involvement of protein kinase C-dependent phosphorylation.
    Merrill JT; Slade SG; Weissmann G; Winchester R; Buyon JP
    J Immunol; 1990 Oct; 145(8):2608-15. PubMed ID: 1976698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of lipopolysaccharide-induced priming of human neutrophils by lipid A analogs.
    Van Dervort AL; Doerfler ME; Stuetz P; Danner RL
    J Immunol; 1992 Jul; 149(1):359-66. PubMed ID: 1318905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analogue of lipid A and LPS from Rhodobacter sphaeroides inhibits neutrophil responses to LPS by blocking receptor recognition of LPS and by depleting LPS-binding protein in plasma.
    Aida Y; Kusumoto K; Nakatomi K; Takada H; Pabst MJ; Maeda K
    J Leukoc Biol; 1995 Dec; 58(6):675-82. PubMed ID: 7499965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.